Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: Everolimus|DRUG: Aromatase Inhibitors
Sponsor: Istituto Oncologico Veneto IRCCS
Collaborators: University of Padova